These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 11655169)
41. FDA's new rule on treatment use and sale of investigational new drugs. Levine RJ IRB; 1987; 9(4):1-4. PubMed ID: 11649946 [No Abstract] [Full Text] [Related]
42. Protection of human subjects; prisoners used as research subjects; reproposal of regulations. U.S. Food and Drug Administration Fed Regist; 1981 Dec; 46(243):61666-71. PubMed ID: 11655490 [No Abstract] [Full Text] [Related]
43. Constraints on experimentation: protecting children to death. Holder AR Yale Law Policy Rev; 1988; 6(1):137-56. PubMed ID: 11650241 [No Abstract] [Full Text] [Related]
44. Informed consent in human experimentation: bridging the gap between ethical thought and current practice. Delgado R; Leskovac H UCLA Law Rev; 1986 Oct; 34(1):67-130. PubMed ID: 11659049 [No Abstract] [Full Text] [Related]
45. Neurobiological research involving human subjects: perspectives from the Office for Protection from Research Risks. Puglisi JT; Ellis GB Account Res; 1996; 4(3-4):261-5. PubMed ID: 11654521 [No Abstract] [Full Text] [Related]
46. Protecting research subjects after consent: the case for the "research intermediary. Reiser SJ; Knudson P IRB; 1993; 15(2):10-1. PubMed ID: 11651567 [No Abstract] [Full Text] [Related]
47. Medical and psychological experimentation on California prisoners. Herch F; Flower R Univ Calif Davis Law Rev; 1974; 7():351-84. PubMed ID: 11661107 [No Abstract] [Full Text] [Related]
48. Research in emergency situations. The role of deferred consent. Levine RJ JAMA; 1995 Apr; 273(16):1300-2. PubMed ID: 7715046 [No Abstract] [Full Text] [Related]
50. Questions and answers. Goodwin FK J Calif Alliance Ment Ill; 1994; 5(1):45-7. PubMed ID: 11653321 [No Abstract] [Full Text] [Related]
51. Trends in the social control of medical and psychiatric research. Benson PR; Roth LH Law Ment Health; 1988; 4():1-47. PubMed ID: 11655151 [No Abstract] [Full Text] [Related]
52. Innovative therapy. The responsibility of hospitals. Cowan DH; Bertsch E J Leg Med; 1984 Jun; 5(2):219-51. PubMed ID: 6611383 [No Abstract] [Full Text] [Related]
53. Hospital failed on human research policy. Science; 1998 Nov; 282(5391):1035. PubMed ID: 11645114 [No Abstract] [Full Text] [Related]
54. The FDA's final regulations: IRBs and medical devices. Holder AR IRB; 1980; 2(6):1-4. PubMed ID: 11661803 [No Abstract] [Full Text] [Related]
56. A look at the bioresearch monitoring program: the agency perspective. Brisson EL Food Drug Cosmet Law J; 1983 Apr; 38(2):184-9. PubMed ID: 11649578 [No Abstract] [Full Text] [Related]
57. Research involving children: an interpretation of the new regulations. Levine RJ IRB; 1983; 5(4):1-5. PubMed ID: 11649521 [No Abstract] [Full Text] [Related]
58. IRBs and pharmaceutical company funding of research. Jellinek MS; Levine RJ IRB; 1982 Oct; 4(8):9-10. PubMed ID: 11651693 [No Abstract] [Full Text] [Related]
59. Proposed requirements for informed consent go beyond current federal regulations. Hum Res Rep; 1994 Jul; 9(7):1-3. PubMed ID: 11659879 [No Abstract] [Full Text] [Related]
60. If it's research, it must be reviewed: an NIH reprimand. Levine C Hastings Cent Rep; 1986 Feb; 16(1):2-3. PubMed ID: 11643913 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]